Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Hyperfine (HYPR) Research & Development (2021 - 2026)

Hyperfine filings provide 6 years of Research & Development readings, the most recent being $3.8 million for Q1 2026.

  • On a quarterly basis, Research & Development fell 23.66% to $3.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $16.3 million, a 25.98% decrease, with the full-year FY2025 number at $17.5 million, down 22.44% from a year prior.
  • Research & Development hit $3.8 million in Q1 2026 for Hyperfine, up from $3.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $8.3 million in Q1 2022 to a low of $3.8 million in Q4 2025.
  • Median Research & Development over the past 5 years was $5.5 million (2023), compared with a mean of $5.6 million.
  • The widest YoY moves for Research & Development: up 86.28% in 2022, down 41.31% in 2022.
  • Hyperfine's Research & Development stood at $5.2 million in 2022, then grew by 14.24% to $6.0 million in 2023, then dropped by 14.37% to $5.1 million in 2024, then decreased by 25.07% to $3.8 million in 2025, then increased by 0.52% to $3.8 million in 2026.
  • The last three reported values for Research & Development were $3.8 million (Q1 2026), $3.8 million (Q4 2025), and $4.0 million (Q3 2025) per Business Quant data.